Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Flex Ltd (FLEX) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Flex Ltd vs Vir Biotechnology Inc. Common Stock — how do they compare? Flex Ltd trades at $99.25 (market cap $40.97B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Flex Ltd is far larger — about 22.8× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Flex Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Flex Ltd for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

FLEXVIR
Market Cap
$40.97B$1.80B
Volume
5,533,5541,782,836
Sector
TechnologyHealth
52-Week High
$162.07$11.78
52-Week Low
$54.51$5.12
Typical Hold Time
6 Days0 Days
Enterprise Value
$44.06B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Flex Ltd

FLEX trades at $110.88, down 5.42% over the past day, amid a broader market pullback. The stock maintains a bullish technical trend with strong analyst support, including a consensus price target of $147.50. Recent acquisitions like EPC Power and the planned spin-off of Axiom highlight strategic moves to capitalize on AI data center and power infrastructure growth. Fundamentals show solid profitability with a net income margin of 3.32% and revenue growth to $29.3B projected for 2026.

The outlook for FLEX is positive, driven by expansion in AI infrastructure and consistent earnings beats. Investment opportunities include potential upside from the Axiom spin-off and continued demand in cloud and power sectors. Key risks involve integration challenges from acquisitions, competitive pressures, and market volatility affecting valuation multiples.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FLEX
51% Buy49% Sell
Avg holding period · 6 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Flex Ltd

Flex provides design, engineering, manufacturing, supply chain, and logistics services for technology products. It serves industries including cloud, data centers, communications, automotive, healthcare, and industrials.

Read more on FLEX →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →